FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129351382> ?p ?o ?g. }

• W2129351382 endingPage "185" @default.
• W2129351382 startingPage "179" @default.
• W2129351382 abstract "Background and aims Hyponatremia has been associated with an increased mortality risk in the general population. Diabetes is a condition predisposing for elevated levels of arginine vasopressin (AVP) and heart failure, both common causes of hyponatremia. These factors, however, are also associated with an increased mortality risk. We aimed to investigate whether serum sodium is associated with cardiovascular and all-cause mortality in type 2 diabetes and whether these associations could be explained by copeptin, a surrogate for AVP, or NT-proBNP, a marker for heart failure. Methods Patients with type 2 diabetes participating in the observational ZODIAC study were included. Cox regression analyses were used to investigate the association of serum sodium with mortality. Results We included 1068 patients (age 67 ± 12 years, 45% male, serum sodium 142 ± 3 mmol/L). After 15 years of follow-up, 519 patients (49%) died, with 225 cardiovascular deaths (21%). In univariable analyses, serum sodium, copeptin, and NT-proBNP were all significantly associated with cardiovascular and all-cause mortality. These associations remained significant after combination of these markers in a multivariable model. Serum sodium and NT-proBNP remained significantly associated with mortality after further adjustment for potential confounders, whereas copeptin lost significance after adjustment for SCr and ACR. Conclusion Low serum sodium was associated with an increased risk of cardiovascular and all-cause mortality in type 2 diabetes. Moreover, these associations were not explained by copeptin and NT-proBNP. Whether low serum sodium itself leads to poor outcome or is a marker for (unidentified) co-morbidity severity or use of specific medications remains to be elucidated." @default.
• W2129351382 created "2016-06-24" @default.
• W2129351382 creator A5010367070 @default.
• W2129351382 creator A5015846826 @default.
• W2129351382 creator A5019197669 @default.
• W2129351382 creator A5030097178 @default.
• W2129351382 creator A5032724022 @default.
• W2129351382 creator A5038949732 @default.
• W2129351382 creator A5050900629 @default.
• W2129351382 creator A5051705276 @default.
• W2129351382 creator A5054266211 @default.
• W2129351382 creator A5058394421 @default.
• W2129351382 creator A5075995015 @default.
• W2129351382 creator A5080824682 @default.
• W2129351382 date "2015-09-01" @default.
• W2129351382 modified "2023-10-14" @default.
• W2129351382 title "Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46)" @default.
• W2129351382 cites W2004852448 @default.
• W2129351382 cites W2011789834 @default.
• W2129351382 cites W2017190445 @default.
• W2129351382 cites W2025266397 @default.
• W2129351382 cites W2028044474 @default.
• W2129351382 cites W2028757623 @default.
• W2129351382 cites W2034129937 @default.
• W2129351382 cites W2039994300 @default.
• W2129351382 cites W2047575871 @default.
• W2129351382 cites W2048739165 @default.
• W2129351382 cites W2051129767 @default.
• W2129351382 cites W2055350549 @default.
• W2129351382 cites W2062396912 @default.
• W2129351382 cites W2064249981 @default.
• W2129351382 cites W2065974896 @default.
• W2129351382 cites W2075117520 @default.
• W2129351382 cites W2080006179 @default.
• W2129351382 cites W2091020688 @default.
• W2129351382 cites W2105820627 @default.
• W2129351382 cites W2113002312 @default.
• W2129351382 cites W2117439565 @default.
• W2129351382 cites W2120561016 @default.
• W2129351382 cites W2126135055 @default.
• W2129351382 cites W2128280910 @default.
• W2129351382 cites W2142883378 @default.
• W2129351382 cites W2144352652 @default.
• W2129351382 cites W2146105386 @default.
• W2129351382 cites W2151004739 @default.
• W2129351382 cites W2151348753 @default.
• W2129351382 cites W2153191747 @default.
• W2129351382 cites W2155965977 @default.
• W2129351382 cites W2169518471 @default.
• W2129351382 cites W4252928828 @default.
• W2129351382 doi "https://doi.org/10.1016/j.atherosclerosis.2015.07.010" @default.
• W2129351382 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26201002" @default.
• W2129351382 hasPublicationYear "2015" @default.
• W2129351382 type Work @default.
• W2129351382 sameAs 2129351382 @default.
• W2129351382 citedByCount "9" @default.
• W2129351382 countsByYear W21293513822016 @default.
• W2129351382 countsByYear W21293513822017 @default.
• W2129351382 countsByYear W21293513822018 @default.
• W2129351382 countsByYear W21293513822021 @default.
• W2129351382 countsByYear W21293513822022 @default.
• W2129351382 crossrefType "journal-article" @default.
• W2129351382 hasAuthorship W2129351382A5010367070 @default.
• W2129351382 hasAuthorship W2129351382A5015846826 @default.
• W2129351382 hasAuthorship W2129351382A5019197669 @default.
• W2129351382 hasAuthorship W2129351382A5030097178 @default.
• W2129351382 hasAuthorship W2129351382A5032724022 @default.
• W2129351382 hasAuthorship W2129351382A5038949732 @default.
• W2129351382 hasAuthorship W2129351382A5050900629 @default.
• W2129351382 hasAuthorship W2129351382A5051705276 @default.
• W2129351382 hasAuthorship W2129351382A5054266211 @default.
• W2129351382 hasAuthorship W2129351382A5058394421 @default.
• W2129351382 hasAuthorship W2129351382A5075995015 @default.
• W2129351382 hasAuthorship W2129351382A5080824682 @default.
• W2129351382 hasConcept C126322002 @default.
• W2129351382 hasConcept C134018914 @default.
• W2129351382 hasConcept C164705383 @default.
• W2129351382 hasConcept C2776370428 @default.
• W2129351382 hasConcept C2776703092 @default.
• W2129351382 hasConcept C2777180221 @default.
• W2129351382 hasConcept C2778198053 @default.
• W2129351382 hasConcept C2779311642 @default.
• W2129351382 hasConcept C50382708 @default.
• W2129351382 hasConcept C555293320 @default.
• W2129351382 hasConcept C71924100 @default.
• W2129351382 hasConcept C77350462 @default.
• W2129351382 hasConceptScore W2129351382C126322002 @default.
• W2129351382 hasConceptScore W2129351382C134018914 @default.
• W2129351382 hasConceptScore W2129351382C164705383 @default.
• W2129351382 hasConceptScore W2129351382C2776370428 @default.
• W2129351382 hasConceptScore W2129351382C2776703092 @default.
• W2129351382 hasConceptScore W2129351382C2777180221 @default.
• W2129351382 hasConceptScore W2129351382C2778198053 @default.
• W2129351382 hasConceptScore W2129351382C2779311642 @default.
• W2129351382 hasConceptScore W2129351382C50382708 @default.
• W2129351382 hasConceptScore W2129351382C555293320 @default.
• W2129351382 hasConceptScore W2129351382C71924100 @default.
• W2129351382 hasConceptScore W2129351382C77350462 @default.

• next